Jon Jones Passed UFC 232 Fight Night Drug Tests!

Jon Jones’ Sample From The Night He Fought Alexander Gustafsson Contained No Traces Of M3 Metabolite!

Finally, great news for the current UFC Light Heavyweight champion! Brett Okamoto from ESPN announced that Jon Jones’ drug test results from December 29, 2018, when he fought Alexander Gustafsson, came back clean! There were no M3 metabolite traces at all!

Breaking: Jon Jones was drug tested by USADA and the California State Athletic Commission on the night of UFC 232 on Dec. 29 and all tests have come back clean. No picograms of the M3 metabolite, which was the source of all the controversy and drama last month, were found.

Let’s remember, Jon Jones was already punished once because of this substance. At UFC 214, he initially won Daniel Cormier via head kick KO, but CSAC overturned the match to no contest after positive drug test results. He was issued a 15-month penalty later.

The M3 metabolite was the reason for suspicious drug test results and UFC 232 fiasco. The whole fight card was relocated from Nevada to high-tax California. It was done on a short notice to keep the main event between Jon Jones and Alexander Gustafsson intact after NSAC didn’t grant “Bones” a license for the fight, citing “lack of time to investigate”.

After a controversial test result, Jon accepted to take part in both USADA and VADA testing to prove his innocence.

As well as you know, Jones is booked to defend his title versus Anthony “Lionheart” Smith at UFC 235 on March 2, 2019, in Las Vegas, Nevada. But the match cannot come to fruition until “Bones” gets a new license from NSAC. The latest findings should definitively help him with that.

Do you think NSAC will finally allow Jon Jones to fight in Nevada? Will Jones’ steroid controversy ever come to an end?

For more MMA News, Rumors and Updates follow the Red Monster on Facebook, Twitter, YouTube and Instagram

Join our list

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

LEAVE A REPLY

Please enter your comment!
Please enter your name here